|
Korea United Pharmaceutical Incorporated - Comparative Business Analysis Snapshot
Business Description
Korea United Pharmaceutical Incorporated. The Company's principal activities are manufacturing and distributing pharmaceuticals. The Company's core offerings include anticancer drugs for cancer of digestive organ, breast and ovary, malignant tumor and myelogenous leukemia; antibiotics for various infection; circulatory drugs used to treat hypertension, stenocardia, diabetes and other disease of circulatory organ; vitamins for weak constitution and vitamin deficiency diseases; antifebrile and anodynes for arthritis, period pains and pain after surgery, and digestive system drugs used to cure gastric ulcer, gastritis, duodenal ulcer and others. The Company is also involved in the research and development of new drugs through its research center in Korea.
Competitor Analysis
This analysis compares Korea United Pharmaceutical Incorporated with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
